Coma, Seizures, Atrioventricular Block, and Hypoglycemia in an ADB-FUBINACA Body-Packer
- 1 December 2018
- journal article
- research article
- Published by Elsevier in The Journal of Emergency Medicine
- Vol. 55 (6) , 788-791
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health/National Institute on Drug Abuse (DA039143)
This publication has 7 references indexed in Scilit:
- Reports of adverse health effects related to synthetic cannabinoid use in New York StateThe American Journal on Addictions, 2017
- Acute side effects after consumption of the new synthetic cannabinoids AB-CHMINACA and MDMB-CHMICAClinical Toxicology, 2017
- Supraventricular tachycardia and acute confusion following ingestion of e-cigarette fluid containing AB-FUBINACA and ADB-FUBINACA: a case report with quantitative analysis of serum drug concentrationsClinical Toxicology, 2017
- “Zombie” Outbreak Caused by the Synthetic Cannabinoid AMB-FUBINACA in New YorkNew England Journal of Medicine, 2017
- Analysis and clinical findings of cases positive for the novel synthetic cannabinoid receptor agonist MDMB-CHMICAClinical Toxicology, 2016
- Death Associated With the Use of the Synthetic Cannabinoid ADB-FUBINACAJournal of Analytical Toxicology, 2016
- Pharmacology of Indole and Indazole Synthetic Cannabinoid Designer Drugs AB-FUBINACA, ADB-FUBINACA, AB-PINACA, ADB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, ADBICA, and 5F-ADBICAACS Chemical Neuroscience, 2015